tadalafil has been researched along with Pulmonary Fibrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Abhar, HS; Mansour, SM; Soubh, AA | 1 |
| Ishii, H; Kinoshita, Y; Kushima, H; Nabeshima, K; Watanabe, K | 1 |
| El-Kersh, K; Fraig, M; Perez, RL; Smith, JS | 1 |
| Ando, K; Hoshika, Y; Ienaga, H; Kimura, T; Kuraishi, H; Morio, Y; Nagaoka, T; Takahashi, K; Tsutsumi, T | 1 |
4 other study(ies) available for tadalafil and Pulmonary Fibrosis
| Article | Year |
|---|---|
MiR-200a inversely correlates with Hedgehog and TGF-β canonical/non-canonical trajectories to orchestrate the anti-fibrotic effect of Tadalafil in a bleomycin-induced pulmonary fibrosis model.
Topics: Animals; Bleomycin; Dexamethasone; Disease Models, Animal; Hedgehog Proteins; Male; MicroRNAs; Phosphodiesterase 5 Inhibitors; Pulmonary Fibrosis; Rats; Rats, Wistar; Tadalafil; Transforming Growth Factor beta | 2021 |
Lower-lobe predominant pleuroparenchymal fibroelastosis.
Topics: Adrenal Cortex Hormones; Aged; Autopsy; Dermatomyositis; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Parenchymal Tissue; Phosphodiesterase 5 Inhibitors; Pleura; Pleural Diseases; Pulmonary Fibrosis; Tadalafil; Tomography, X-Ray Computed | 2019 |
Smoking-related interstitial fibrosis (SRIF) and pulmonary hypertension.
Topics: Antihypertensive Agents; Biopsy; Bosentan; Carbolines; Cardiac Catheterization; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Fibrosis; Respiratory Function Tests; Smoking; Sulfonamides; Tadalafil; Tomography, X-Ray Computed; Vasodilator Agents | 2013 |
Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
Topics: Aged; Bosentan; Endothelin Receptor Antagonists; Exercise Test; Female; Forced Expiratory Volume; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Artery; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Sildenafil Citrate; Sulfonamides; Tadalafil; Tomography, X-Ray Computed; Vasodilator Agents; Vital Capacity | 2015 |